SCD-CARRE Study

I'm Interested!

Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE)

Sex: Any
Age: Adult (18 - 64), Older Adult (65+)
Accepting Healthy People: No
Type: Interventional / Therapeutic
Trial Phase: Phase III
Conditions Being Studied: Sickle Cell Anemia

Study Purpose

The purpose of this study is to see the effects of giving long-term red blood cell exchange transfusion to patients with sickle cell disease (SCD). We want to know if exchange blood transfusion may help with complications of SCD or reduce the chances of new serious problems happening.

Who Can Participate

Participants 18 years old and older with a diagnosis of sickle cell disease may be eligible for this study.

Principal Investigator
Robert Maitta MD PhD

Department/Division
Pathology/Lab Medicine (Clinical Pathology)

Locations

UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106

Get Directions

UH IRB: SITE00001822 (STUDY20221183)
StudyID: 2022-01082
ClinicalTrials.gov: NCT04084080

I'm Interested!

Fill out our online form

Questions or concerns? We're here to help.

Non-cancer Trials: 1-833-78TRIAL or Contact Us Online

Cancer Trials: 1-800-641-2422